...
首页> 外文期刊>NeuroImage >Quantitative in vivo measurement of early axonal transport deficits in a triple transgenic mouse model of Alzheimer's disease using manganese-enhanced MRI.
【24h】

Quantitative in vivo measurement of early axonal transport deficits in a triple transgenic mouse model of Alzheimer's disease using manganese-enhanced MRI.

机译:使用锰增强MRI的阿尔茨海默氏病三重转基因小鼠模型中的早期轴突运输缺陷的体内定量测量。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Impaired axonal transport has been linked to the pathogenic processes of Alzheimer's disease (AD) in which axonal swelling and degeneration are prevalent. The development of non-invasive neuroimaging methods to quantitatively assess in vivo axonal transport deficits would be enormously valuable to visualize early, yet subtle, changes in the AD brain, to monitor the disease progression and to quantify the effect of drug intervention. A triple transgenic mouse model of AD closely resembles human AD neuropathology. In this study, we investigated age-dependent alterations of the axonal transport rate in the triple transgenic mouse olfactory system, using fast multi-sliced T(1) mapping with manganese-enhanced MRI. The data show that impairment in axonal transport is a very early event in AD pathology in these mice, preceding both deposition of Abeta plaques and formation of Tau fibrils.
机译:轴突运输受损与阿尔茨海默氏病(AD)的致病过程有关,其中轴突肿胀和变性普遍存在。定量评估体内轴突运输缺陷的非侵入性神经影像学方法的发展对于可视化AD脑的早期但微妙的变化,监测疾病的进展并量化药物干预的效果将具有巨大的价值。 AD的三重转基因小鼠模型与人AD神经病理学非常相似。在这项研究中,我们使用锰增强的MRI快速多层T(1)作图,研究了三重转基因小鼠嗅觉系统中轴突运输速率的年龄依赖性变化。数据显示,在这些小鼠中,轴突运输中的损伤是AD病理学中非常早的事件,先于Abeta斑块沉积和Tau原纤维形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号